Apo-Metoclop en es it fr

Apo-Metoclop Brand names, Apo-Metoclop Analogs

Apo-Metoclop Brand Names Mixture

  • No information avaliable

Apo-Metoclop Chemical_Formula


Apo-Metoclop RX_link


Apo-Metoclop fda sheet

Apo-Metoclop FDA

Apo-Metoclop msds (material safety sheet)

Apo-Metoclop MSDS

Apo-Metoclop Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Apo-Metoclop Molecular Weight

299.796 g/mol

Apo-Metoclop Melting Point

147.25 oC

Apo-Metoclop H2O Solubility

200 mg/L

Apo-Metoclop State


Apo-Metoclop LogP


Apo-Metoclop Dosage Forms

Liquid; Syrup; Tablet

Apo-Metoclop Indication

For the treatment of gastroesophageal reflux disease (GERD)

Apo-Metoclop Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Apo-Metoclop Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Apo-Metoclop side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Apo-Metoclop Patient Information

Apo-Metoclop Organisms Affected

Humans and other mammals